missing translation for 'onlineSavingsMsg'
Learn More
Learn More
R&D Systems™ Recombinant Human PD-L1/B7-H1 Fc Alexa Fluor™ 647 Protein
Descripción
Measured by flow cytometry for its ability to bind anti-human PD-L1/B7-H1 Monoclonal Antibody conjugated beads. The concentration of Recombinant Human PD-L1/B7-H1 Fc Chimera Alexa Fluor™ 647 (Catalog # AFR156) that produces 50% of the binding response is 1.00-15.0 ng/mL.
Especificaciones
Especificaciones
| Número de acceso | Q9NZQ7.1 |
| Para utilizar con (aplicación) | Bioactivity |
| Formulación | Supplied as a 0.2 μm filtered solution in PBS and NaCl with BSA as a carrier protein. |
| ID de gen (Entrez) | 29126 |
| Peso molecular | MolecularWeight-observed: 70-75 kDa, under reducing conditions., MolecularWeight-theroretical: 52 kDa (monomer) |
| Cantidad | 20 μg |
| Fuente | Mouse myeloma cell line, NS0-derived human PD-L1/B7-H1 protein Human PD-L1 (Phe19-Thr239) (N-terminus) Accession # Q9NZQ7.1 DIEGRMD Human IgG1 (Pro100-Lys330) (C-terminus) |
| Requisitos de almacenamiento | Protect from light. Use a manual defrost freezer and avoid repeated freeze-thaw cycles. 6 months from date of receipt, -20°C to -70°C as supplied. 1 month, 2°C to 8°C under sterile conditions after opening. 3 months, -20°C to -70°C under sterile conditions after opening. |
| Concentración de endotoxinas | <1.0 EU / 1 μg of the protein by the LAL method. |
| Alias de gen | Avelumab, B7-H, B7H1, B7-H1, B7H1PDCD1L1, CD274, CD274 antigenMGC142294, CD274 molecule, PDCD1L1, PDCD1LG1, PDCD1LG1MGC142296, PDL1, PD-L1, PD-L1B7 homolog 1, PDL1PDCD1 ligand 1, programmed cell death 1 ligand 1, Programmed death ligand 1 |
| Mostrar más |
Título del producto
Al hacer clic en Enviar, acepta que Fisher Scientific se ponga en contacto con usted en relación con los comentarios que ha proporcionado en este formulario. No compartiremos su información para ningún otro fin. Toda la información de contacto proporcionada se mantendrá de acuerdo con nuestra Política de Privacidad. Política de privacidad.
¿Detecta una oportunidad de mejora?